Last update :
17/04/2024
Anticancer drug   Bleomycin sulfate  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Bileco Argentina
Blemisin Turkey
Blenamax Australia, Colombia, Malaysia
Blenoxane Australia, United States of America
Bleo-Kyowa Great Britain
Bleocell Germany
Bleocin Greece, Hungary, Japan, Malaysia, Peru, Poland, Portugal, Saudi Arabia, Turkey, United Arab Emirates
Bleocip Egypt, Venezuela
Bleocris Argentina, Chile, Peru
Bleolem Colombia, Mexico
Bleomax Mexico
Bleomedac Germany
Bleomicina Chile, Colombia, Ecuador, Italy, Mexico, Peru, Spain
Bleomycin Australia, Austria, Denmark, Finland, Germany, Great Britain, Hungary, Iceland, Iran, Netherlands, Norway, Poland, Romania, Sweden, United States of America
Bleomycine Belgium, Canada, France, Ireland, Luxembourg, Malaysia, Morocco, New Zealand, Switzerland, Tunisia
Bleomycine A Denmark
Bleomycinum Germany
Bleozen Peru
Blexit Chile
Blocamicina Argentina
Bloicin Egypt, Peru
Blomindex Mexico
Blucin Morocco
DBL Bleomycin Malaysia, New Zealand
Ifabec Mexico
Lyoble Peru
Nikableocina Chile
Oncobleocin Colombia
Stability in solutions   Injection   Stability in solutions : Bleomycin sulfate     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass Sodium chloride 0,9% 0,3 & 3 mg/ml 22°C-25°C Not specified
24 Hour
252
Level of evidence C

Glass Sodium chloride 0,9% 3 mg/ml 2-8°C Not specified
24 Hour
3646
Manufacturer's stability data

Polyvinyl chloride Sodium chloride 0,9% 0,3 & 3 mg/ml 22°C-25°C Not specified
24 Hour
252
Level of evidence C

Polypropylene Sodium chloride 0,9% 0,75 mg/ml 22°C Protect from light
7 Day
3420
Level of evidence A

Polypropylene Sodium chloride 0,9% 0,75 mg/ml 4°C Protect from light
7 Day
3420
Level of evidence A


  Mentions Légales